Wash U Genome Center to Use NanoString nCounter for Diabetes Study | GenomeWeb
NEW YORK (GenomeWeb News) – The Genome Sequencing Center at the Washington University School of Medicine will use NanoString Technologies’ digital gene expression technology in a large-scale diabetes study, NanoString said today.
 
NanoString said that Wash U is the second customer under its early-access program for the nCounter Analysis System, following the California Institute of Technology, which signed on for the system last month.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.